ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1003

Significant Enrichment of Pathogenic CD206+CD163+ Macrophages in Rheumatoid Arthritis Synovial Tissue with Distinct Transcriptional Signatures

Megan Hanlon1, Mary Canavan2, Nuno Neto3, Qingxuan Song4, Phil Gallagher5, Ronan Mullan6, Conor Hurson7, Barry Moran3, Michael Monaghan3, Sunil Nagpal8, Douglas Veale9 and Ursula Fearon3, 1Molecular Rheumatology, Dublin, Ireland, 2Trinity College, Santry, Ireland, 3Trinity College Dublin, Dublin, Ireland, 4Janssen Research & Development LLC, Spring House, PA, 5St Vincent's Hospital, Dublin, Ireland, 6Tallaght University Hospital, Dublin, Ireland, 7St Vincents University Hospital, Dublin, Ireland, 8Janssen Research, Collegeville, PA, 9University College Dublin, Dublin, Ireland

Meeting: ACR Convergence 2021

Keywords: cytokines, Fibroblasts, Synovial, innate immunity, macrophages, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Title: Innate Immunity Poster (0992–1006)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Synovial tissue macrophages are an exquisitely plastic pool of innate cells that play a key role in RA disease progression. However, the precise nature, diversity, and function of macrophage subsets within the inflamed joint remains unexplored. Therefore, the aims of this study are to phenotypically, transcriptionally and functionally characterise synovial tissue macrophages residing within the inflamed joint.

Methods: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Osteoarthritis (OA), Arthralgia and healthy control synovial tissue biopsies and synovial fluid mononuclear cells were analysed using the following panel (CD40,-CD45,-CD64,-CD68,-CD163,-CD206,-CD253,-CCR4,-CCR7,-CXCR1,-CXCR3). CD206+CD163+ and CD206-CD163- macrophages were sorted from RA synovial-tissue by FACSAria sorter; RNAseq and FLIM analysis, autologous T-cell co-culture and heathy synovial fibroblast experiments were performed. Cytokine expression was measured by MSD.

Results: A spectrum of macrophage activation states exists within the inflamed synovium. Within this spectrum, significant enrichment of dominant CD206+CD163+ macrophage subtype is present in synovial-tissue versus fluid (p< 0.05). CD206+CD163+ synovial tissue macrophages express significantly more CD40 than synovial fluid (p< 0.0003), positively correlating with disease activity (r=0.6, p< 0.01), with baseline levels predicting response to therapy (p< 0.05). Moreover, CD206+CD163+CD40+ macrophages are enriched in RA synovial tissue compared to PsA and OA pathotypes (p< 0.05). While the CD206+CD163+ subset is present in healthy synovial tissue, expression of CD40 is completely absent in healthy synovium (p< 0.05). Protective barrier-like CX3CR1-expressing macrophages are depleted in RA synovial tissue and this occurs prior to clinical manifestations. RNA-seq analysis indicates that CD206+CD163+ population is transcriptionally distinct from synovial tissue CD206-CD163-, synovial fluid CD206+CD163+, and RA monocyte-derived M1/M2 macrophages, with unique tissue-resident gene signatures. Moreover, differing metabolic demands between CD206+CD163+ and CD206-CD163- subsets was demonstrated by RNAseq and FLIM analysis. Finally, CD206+CD163+ macrophages spontaneously secrete high levels of key pro-inflammatory mediators (reversed through inhibition of CD40 signalling) which in turn can activate healthy synovial fibroblasts, thus further contributing to the local inflammatory response.

Conclusion: This data identifies for the first-time enrichment of a previously undescribed dysfunctional dominant and transcriptionally distinct macrophage subtype in RA synovial tissue. Taken together, this data provides a greater understanding of the critical role tissue-resident macrophages play in perpetuating inflammation in RA. Further investigation of the molecular patterns and cues that shape specific synovial macrophage subsets may provide opportunities to reinstate RA joint homeostasis.


Disclosures: M. Hanlon, None; M. Canavan, None; N. Neto, None; Q. Song, Janssen Research and Development, LLC (a subsidiary of Johnson & Johnson), 3, 11; P. Gallagher, None; R. Mullan, None; C. Hurson, None; B. Moran, None; M. Monaghan, None; S. Nagpal, None; D. Veale, Abbvie, 1, 5, 6, BMS, 1, 5, Pfizer, 1, 5, 6, Janssen, 1, 5, 6, Eli Lilly, 1, 5, 6, UCB, 1, 5, 6, Novartis, 1, 5, 6, Galapagos/Gilead, 1, 6; U. Fearon, Abbvie, 1, 5, 6, BMS, 1, Pfizer, 1, 5, Janssen, 5, Eli Lilly, 5, UCB, 5, GSK, 6.

To cite this abstract in AMA style:

Hanlon M, Canavan M, Neto N, Song Q, Gallagher P, Mullan R, Hurson C, Moran B, Monaghan M, Nagpal S, Veale D, Fearon U. Significant Enrichment of Pathogenic CD206+CD163+ Macrophages in Rheumatoid Arthritis Synovial Tissue with Distinct Transcriptional Signatures [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/significant-enrichment-of-pathogenic-cd206cd163-macrophages-in-rheumatoid-arthritis-synovial-tissue-with-distinct-transcriptional-signatures/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/significant-enrichment-of-pathogenic-cd206cd163-macrophages-in-rheumatoid-arthritis-synovial-tissue-with-distinct-transcriptional-signatures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology